In poultry drinking water delivery, Maxingshigan Oral Solution Veterinary Grade API is normally compounded into a finished oral solution or a farm-level stock solution. A two-stage batching sequence reduces the risk of local viscosity gradients and dose variation. In the first stage, the API concentrate is introduced at 500–1,000 mL per 1,000 L of final drinking water into a 100 L 316L stainless steel pre-mix tank fitted with a low-shear impeller. The first-stage solution is mixed for 5–10 min at 20–25 °C, then transferred through a peristaltic pump into the bulk tank, where the final solution is agitated at 200–300 rpm for an additional 10 min. The terminal finished product is a 500 mL or 5 L oral solution bottle; farm proportioner systems may draw from a stock solution prepared at a 1:10 dilution. Release specifications follow the CVP 2020 oral solution monograph where applicable and veterinary GMP, with batch tests for pH, relative density, microbial enumeration, and Ephedra alkaloid marker assay. Dilution water must be free of residual chlorine and hardness should remain below 250 ppm CaCO₃; harder water produces calcium sulfate sediment from the gypsum fraction, and the resulting particles block nipple drinkers and create dose variation. The product is not pyrogen-validated for injectable use.

Operational limits are narrow in this route. If the diluted solution is held longer than 24 h at 25 °C, microbial growth in non-preserved water lines becomes a batch-release risk. If pH falls below 4.0 because of acid sanitizer residues, glycyrrhizic acid can precipitate as a sticky film on tank walls and proportioner diaphragms. Before dosing pump installation, the viscosity of the 1:10 pre-dilution is measured with a rotational viscometer according to ISO 3219; if the measured value exceeds 50 mPa·s at 20 °C, pump calibration must be repeated to avoid under-delivery. Inline strainers of 50-mesh are placed upstream of nipple lines to arrest visible particulate matter generated during hard-water dilution or pH drift.

Why Does Batch-to-Batch Viscosity Shift in Swine Drinking Water Concentrates?

Swine oral solutions are formulated at a higher API concentration because the farm dose is usually metered through proportioners or dosing cups. A working formulation uses 5–10% v/v API in the finished oral solution, followed by a farm dilution of 1 L concentrate per 1,000 L of drinking water. The compounding process uses a 200 L jacketed vessel with a rotor-stator homogenizer at 1,500 rpm, maintained at 25–30 °C; viscosity is measured after a 30 min rest per ISO 3219. The finished product is a 1 L, 5 L, or 25 L oral solution container with a sealed dosing cup. Compliance is documented under Regulation (EU) 2019/6 for veterinary medicinal products, and the import dossier includes stability data aligned to VICH GL18. Active marker content, pH, and microbial limits are tested on each batch.

Viscosity drift on this scale is generally caused by resinous glycyrrhizic acid agglomeration when pH falls below 4.5 or when mixing temperature exceeds 40 °C. In production, a 50-mesh inline filter is placed upstream of the filling line to trap visible particles. The API is incompatible with strong oxidizing sanitizers, and diaphragm valves must be rinsed with hot water after each shift because the extract forms a sticky film on seals. If the finished solution is stored below 10 °C, its viscosity may increase enough to require recalibration of dosing pumps.

When converting the liquid API into a water-soluble powder, the carrier system must have enough oil-holding capacity to accept the extract without forming lumps. In a 100 L horizontal ribbon blender filled to 60% capacity, the liquid API is sprayed at 20–30% w/w onto a carrier blend of glucose and maltodextrin; 1–2% precipitated silica is included as a flow aid. Mixing continues for 10 min after the spray period, and the blend is passed through a 500 µm sieve according to ISO 3310-1. Particle size distribution is checked by laser diffraction per ISO 13320, with D90 maintained below 800 µm. The terminal finished product is a 100 g, 500 g, or 1 kg water-soluble powder pouch, used at 200–500 g per 1,000 L of drinking water. The powder is manufactured under veterinary GMP and tested for loss on drying, active marker content, and uniformity of mass.

The primary failure mode is moisture uptake; if the carrier moisture content exceeds 6% before adsorption, the powder agglomerates and dispersion time in field water lines increases. A solubility check requires complete dispersion within 3 min in water at 25 °C. The powder route is not suitable for direct dry blending into high-fat feeds because the uncoated extract fraction can bind to fat particles and create uneven active distribution.

Low-Dust Premix Adsorbates and the Coefficient of Variation Limit

Medicated premix production uses the liquid API as a spray-on feed ingredient rather than a dry botanical powder, which reduces dust but increases the risk of mixing dead zones. In a 500 kg double-shaft paddle mixer, the API is introduced at 10–15% w/w of the premix through a liquid spray bar, followed by 15 min blending. Sampling is performed at 10 static points in line with ISO 6497, and active marker uniformity is acceptable when the coefficient of variation is ≤5.0%. The terminal product form is a 1 kg or 25 kg premix bag for feed mill addition at 2–5 kg per 1,000 kg complete feed. Compliance is established under Regulation (EU) 2019/6, and stability data are generated under VICH GL18 at 30 °C/65% RH for 12 months.

At production scale, the spray bar can accumulate a sticky extract film when relative humidity exceeds 60%, especially in unheated mixing rooms. The bar and mixer discharge gate must be cleaned daily. Premix packed in unlined paper kraft bags should not be stored beyond 30 days under humid conditions because moisture uptake reduces flowability and increases label claim drift.

When the Extract Is Wet-Granulated for Tablets, the Granulation Endpoint Must Account for Ambient Humidity

Tablet and capsule manufacture from the oral solution API is performed by evaporating or adsorbing the liquid onto a pharmaceutically acceptable carrier before wet granulation. A typical dry-blend addition is 15–30% w/w of the granulation mass, with the liquid extract first sprayed onto a lactose–starch bed in a high-shear granulator at 25–30 °C. The wet mass is passed through a 1.0 mm screen and dried in a fluid-bed dryer at 45–55 °C until loss on drying is less than 3%. The dried granules are lubricated with 0.5% magnesium stearate and compressed into tablets or filled into capsules. The terminal finished product is a 250 mg or 500 mg large-animal tablet or capsule. Tablet weight variation is controlled per Ph. Eur. 2.9.40, and disintegration is tested according to USP <701>.

Humidity is the critical variable: when conditioned air in the granulation suite exceeds 55% RH, the extract powder absorbs moisture, over-granulates, and sticks to punch faces. Tablets produced from this API grade are not intended for injectable use; a separate apyrogenicity validation and further purification would be required. The capsule route is preferred over compression when the extract fraction is not sufficiently dry or when tablet hardness below 50 N is likely, because capsule filling tolerates a wider granule size distribution.

Thermal Degradation Pathways in Post-Pellet Liquid Coating of Swine and Poultry Granules

Granulated feed carriers allow the liquid API to be applied after pelleting, thereby avoiding steam conditioning that can reduce heat-sensitive marker recovery. When pre-pellet addition is unavoidable, the API is included at 1–3% w/w of the dry feed mass; if the conditioning temperature exceeds 75 °C, a separate post-pellet liquid spraying line is used instead of pre-pellet mixing. Pellets are produced with a 3–4 mm die and a compression ratio of 1:8–1:10, then cooled to below 25 °C before the liquid API is sprayed at 2–4 L/t in a drum or belt coater. The terminal product is a 20 kg or 25 kg granule or pellet bag with an inner PE liner. Process validation follows feed safety management under ISO 22000 and stability testing aligned to VICH GL18. Published data for this specific API in post-pellet coating is limited; forced-degradation batches should be run before scale-up to confirm marker recovery.

The operational boundary is set at 75 °C at the conditioner outlet. Above this threshold, the botanical alkaloid fraction may show recovery drift, and the liquid API should not be sprayed into the conditioner. The coating drum must be maintained below 65% RH; otherwise the extract adheres unevenly to pellet surfaces and produces off-spec fines that separate during bulk transport.

Calcium Sulfate Precipitation in Hard-Water Drench Dilutions

Before drench filling begins, the liquid API is compounded into a water-glycerol vehicle to allow calibrated drench gun delivery. The API is compounded at 10–20% v/v, with propylene glycol or glycerol at 5–10% to reduce freezing and reduce viscosity at low temperatures. The mixture is homogenized in a 100 L reactor at 25–30 °C. The farm dose is 0.2–0.5 mL/kg body weight, administered through a drench gun calibrated for 5 mL strokes. The terminal finished product is a 1 L or 5 L oral drench bottle. Release tests include uniformity of dosage units per Ph. Eur. 2.9.40 and active marker assay, under EU GMP Part II for active substances.

Hard water remains the main field limitation. When calcium hardness exceeds 180 mg/L, calcium sulfate from the gypsum fraction can sediment in the drench gun nozzle, requiring a 35-mesh inline filter. Viscosity is controlled at 10–30 mPa·s at 25 °C per ISO 3219; if viscosity exceeds this range, dose variation becomes visible in piston-type guns. The oral-solution grade is not pyrogen-validated, so the formulation is restricted to oral routes and must not be processed into injectable products.